Location History:
- Chapel Hill, NC (US) (1999)
- San Carlos, CA (US) (2006)
Company Filing History:
Years Active: 1999-2006
Title: Jurgen M Lehmann: Innovator in Nuclear Receptor Research
Introduction
Jurgen M Lehmann is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of nuclear receptor research, holding a total of 3 patents. His work focuses on the development of innovative methods and compounds that enhance our understanding of nuclear receptors and their ligands.
Latest Patents
Lehmann's latest patents include groundbreaking inventions such as the "Use of FXR ligands." This invention encompasses nuclear receptor heterodimer and nuclear receptor-coactivator peptide assays for identifying ligands for nuclear receptors. It utilizes scintillation proximity and fluorescence resonance energy transfer (FRET) methods for identifying and utilizing these ligands. Another significant patent is "Activators of the nuclear orphan receptor peroxisome," which provides a radiolabeled compound and a method for determining the interaction of compounds with PPAR-gamma.
Career Highlights
Throughout his career, Jurgen M Lehmann has worked with prominent companies in the pharmaceutical industry, including Glaxo Wellcome Inc. and SmithKline Beecham Corporation. His experience in these organizations has contributed to his expertise in nuclear receptor research and innovation.
Collaborations
Lehmann has collaborated with esteemed colleagues such as Steven Anthony Kliewer and Timothy Mark Willson. These collaborations have further enriched his research and development efforts in the field.
Conclusion
Jurgen M Lehmann is a distinguished inventor whose work in nuclear receptor research has led to valuable patents and advancements in the field. His contributions continue to influence the understanding of nuclear receptors and their potential applications.